Alessia D. S.
- Country
- Italy
- Department
- Neurologia
Research Overview
- Phase 3 Randomized, Double-Blind Study of Frexalimab (SAR441344) Versus Teriflunomide in Adults with Relapsing Multiple Sclerosis
- Evaluation of Satralizumab Efficacy and Safety in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Phase III Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of Autologous Hematopoietic Stem Cell Transplantation and Drug Combination in Aggressive Relapsing-Remitting Multiple Sclerosis
Data & Insights
Has run more than one trial at 7 of 96 partner sites.
Specializations
Neurological Disorders
This investigator specializes in treating various forms of multiple sclerosis, with particular emphasis on aggressive and relapsing-remitting variants. Their research encompasses innovative therapeutic approaches for managing MS symptoms and disease progression.
- Relapsing-Remitting Multiple Sclerosis (RRMS)
- Aggressive Multiple Sclerosis
- Disease Activity Monitoring
The investigator's work includes evaluation of advanced treatment options including autologous haematopoietic stem cell transplantation for MS patients.
Autoimmune Conditions
The investigator focuses on treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD), a rare autoimmune condition affecting the central nervous system. Their work involves evaluating novel therapeutic approaches for managing this condition.
- MOGAD Treatment Development
- Relapse Prevention Strategies
- Antibody-Based Therapies
Their research includes investigating the effectiveness of targeted immunological treatments for autoimmune neurological disorders.
Therapeutic Innovation
The investigator evaluates novel therapeutic agents including satralizumab and frexalimab for neurological conditions. Their work encompasses comprehensive assessment of treatment efficacy and safety profiles.
- Novel Drug Evaluation
- Comparative Treatment Studies
- Disease Activity Assessment
The research includes monitoring of No Evidence of Disease Activity (NEDA) outcomes in neurological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.